Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment
Launched by RIYADH ELM UNIVERSITY · Sep 15, 2023
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
The study will be designed based on the Consolidated Standards of Reporting Trials (CONSORT) and conducted on approval from the Ethics Committee of the University. It will be a randomized controlled trial conducted among 90 pediatric patients of 3 years to 15 years age group. The inclusion criterion for the study will be i) patients in age group of 3 years to 15 years and ii) mucositis (categorized \>1) based on the guidelines of WHO Toxicity Criteria. Pediatric patients having a malignant type of neoplasm and/or clinically evident oral microbial disease and/or with serious medical issues w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients in age group of 3 years to 15 years
- • mucositis (categorized \>1) based on the guidelines of WHO Toxicity Criteria
- • must be able to open the mouth properly
- Exclusion Criteria:
- • Patients with age less than 3 years and more than 15 years of age
- • patients with systemic diseases
About Riyadh Elm University
Riyadh Elm University is a leading educational and research institution in Saudi Arabia, dedicated to advancing healthcare through innovative clinical research and evidence-based practice. Committed to fostering academic excellence and community health, the university collaborates with local and international partners to conduct clinical trials that aim to improve patient outcomes and contribute to the global body of medical knowledge. With a focus on ethical standards and regulatory compliance, Riyadh Elm University seeks to drive advancements in medical science while prioritizing the safety and well-being of participants involved in its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Riyadh, Ar Riyadh, Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported